Virus-like particles based on rotavarus A recombinant VP2/VP6 proteins for assessment the antibody immune response by ELISA
Authors:
- Ilya E. FilatovIFIlya E. Filatov
- Valery V. TsibezovVTValery V. Tsibezov
- Marina V. BalandinaMBMarina V. Balandina
- Svetlana N. NorkinaSNSvetlana N. Norkina
- Oleg E. LatyshevOLOleg E. Latyshev
- Olesia V. EliseevaOEOlesia V. Eliseeva
- Stanislav A. CherepushkinSCStanislav A. Cherepushkin
- Oleg A. VerkhovskyOVOleg A. Verkhovsky
- Tatyana V. GrebennikovaTatyana V. Grebennikova
Open Access
- 18 May 2023
- journal article
- abstracts
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (2) , 161-171
Abstract
Introduction. Rotavirus infection is one of the main concerns in infectious pathology in humans, mammals and birds. Newborn piglets or rodents are usually being used as a laboratory model for the evaluation of immunogenicity and efficacy for all types of vaccines against rotavirus A (RVA), and the use of ELISA for the detection of virus-specific antibodies of specific isotype is an essential step of this evaluation. Objective. Development of indirect solid-phase ELISA with VP2/VP6 rotavirus VLP as an antigen to detect and assess the distribution of RVA-specific IgG, IgM and IgA in the immune response to rotavirus A. Materials and methods. VP2/VP6 rotavirus VLP production and purification, electron microscopy, PAGE, immunoblotting, ELISA, virus neutralization assay. Results. The study presents the results of development of a recombinant baculovirus with RVA genes VP2-eGFP/VP6, assessment of its infectious activity and using it for VLP production. The morphology of the VP2/VP6 rotavirus VLPs was assessed, the structural composition was determined, and the high antigenic activity of the VLP was established. VLP-based ELISA assay was developed and here we report results for RVA-specific antibody detection in sera of different animals. Conclusion. The developed ELISA based on VP2/VP6 rotavirus VLP as a universal antigen makes it possible to detect separately IgG, IgM and IgA antibodies to rotavirus A, outlining its scientific and practical importance for the evaluation of immunogenicity and efficacy of traditional vaccines against rotavirus A and those under development.Keywords
This publication has 20 references indexed in Scilit:
- Process development for pandemic influenza VLP vaccine production using a baculovirus expression systemJournal of Biological Engineering, 2019
- Rotavirus C: prevalence in suckling piglets and development of virus-like particles to assess the influence of maternal immunity on the disease developmentVeterinary Research, 2019
- Rotavirus virus‐like particles (RV‐VLPs) vaccines: An updateReviews in Medical Virology, 2017
- Chimaeric Virus-Like Particles Derived from Consensus Genome Sequences of Human Rotavirus Strains Co-Circulating in AfricaPLOS ONE, 2014
- Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus diseaseExpert Review of Vaccines, 2013
- Secretory IgA's complex roles in immunity and mucosal homeostasis in the gutMucosal Immunology, 2011
- Baculovirus expression systems for production of recombinant proteins in insect and mammalian cellsMolecular Biology, 2011
- The immune geography of IgA induction and functionMucosal Immunology, 2008
- Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a modelVeterinary Immunology and Immunopathology, 2002
- Group A Rotavirus Veterinary VaccinesThe Journal of Infectious Diseases, 1996